Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00929578 · ClinicalTrials.gov registry record · Phase 2
Fluphenazine Hydrochloride for Psoriasis
A Phase 2 study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT00929578 is a Phase 2 study that has completed, run by Tufts Medical Center. The registered enrollment target is 15 participants.
The verdict
NCT00929578, a Phase 2 study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The objective of this study is to assess the safety and biologic activity of intralesional injection of fluphenazine in adult subjects with psoriasis.
Interventions
- DRUG Placebo
- DRUG Fluphenazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00929578
The ClinicalTrials.gov registry entry for NCT00929578 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00929578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00929578 about?
NCT00929578 is a clinical study titled "Fluphenazine Hydrochloride for Psoriasis". The objective of this study is to assess the safety and biologic activity of intralesional injection of fluphenazine in adult subjects with psoriasis.
What is the current status of trial NCT00929578?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2008-11. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00929578?
The interventions under investigation include: Placebo (DRUG), Fluphenazine (DRUG).
Who is sponsoring clinical trial NCT00929578?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.